Sanjay Shrivastava - 16 Nov 2021 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role: Director
Signature: /s/ Sanjay Shrivastava.
Issuer symbol: NVNO
Transactions as of: 16 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 18 Nov 2021, 15:30:03 UTC
Next filing: 02 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVNO	Common Stock	Options Exercise		+388	+16%		2,888	16 Nov 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVNO	Restricted Stock Units	Options Exercise	$0	-388	-100%	$0.000000^*	0	16 Nov 2021	Common Stock	388		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") converts into one share of common stock of enVVeno Medical Corporation.
F2	The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the "Plan"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021.